ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY
William Sandborn 1
Bal R. Bhandari 2
Charles Randall 3
Ziad Younes 4
Tomasz RomaĆczyk 5
Hao Chai 6
Matthew McKevitt
Sally Zhao
Bittoo Kanwar
John Sundy
Satish Keshav
Silvio Danese
1 University of California,San Diego,United States of America
2 Delta Research Partners,Monroe,United States of America
3 Gastroenterology Research of America/U. of Texas,San Antonio,United States of America
4 GastroOne,Germantown,United States of America
5 Takeda Polska Sp. z o.o.,Tychy,Poland
6 Gilead Sciences,Foster City,United States of
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu